ADJUVANT

作品数：496被引量：1918H指数：20
导出分析报告
相关领域：医药卫生更多>>
相关作者：郭虹陈观今郑焕钦许小琴饶平凡更多>>
相关机构：中山大学吉林大学第二军医大学福州大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划中国博士后科学基金高等学校学科创新引智计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 主题=NEOADJUVANTx
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Immunotherapy and liver transplantation for hepatocellular carcinoma:Current and future challenges
《World Journal of Transplantation》2025年第2期8-29,共22页Theodoros Pettas Sofia Lachanoudi Filippos F Karageorgos Ioannis A Ziogas Asimina Fylaktou Vassilios Papalois Georgios Katsanos Nikolaos Antoniadis Georgios Tsoulfas 
Despite existing curative options like surgical removal,tissue destruction techniques,and liver transplantation for early-stage hepatocellular carcinoma(HCC),the rising incidence and mortality rates of this global hea...
关键词：Hepatocellular carcinoma IMMUNOTHERAPY Liver transplantation Neoadjuvant and adjuvant immunotherapy Immune checkpoint inhibitors Vaccine therapies Oncolytic viruses Adoptive cell therapy Antigen-targeting antibodies Diagnostic biomarkers 
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma:a phase Ib trial
《Signal Transduction and Targeted Therapy》2024年第12期5777-5785,共9页Jiayong Liu Xuan Wang Zhongwu Li Shunyu Gao Lili Mao Jie Dai Caili Li Chuanliang Cui Zhihong Chi Xinan Sheng Yumei Lai Zhichao Tan Bin Lian Bixia Tang Xieqiao Yan Siming Li Li Zhou Xiaoting Wei Juan Li Jun Guo Lu Si 
supported by the National Key Research and Development Program(2023YFC2506404);National Natural Science Foundation of China(82372869,82272676,and 82073011);Beijing Municipal Administration of Hospitals’Ascent Plan(DFL20220901,QML20231107);Beijing Natural Science Foundation(7242021).
Neoadjuvant PD-1 inhibitor is promising in cutaneous melanoma but remains unknown in acral melanoma(AM).This phase Ib trial study(Clinicaltrials.gov NCT04197882)assessed the efficacy and safety of the combination of n...
关键词：ADJUVANT MELANOMA surgery 
Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma被引量：6
《World Journal of Gastroenterology》2024年第19期2512-2522,共11页Juan Jose Urquijo-Ponce Carlos Alventosa-Mateu Mercedes Latorre-Sánchez Inmaculada Castelló-Miralles Moisés Diago Hepatology Unit 
Hepatocellular carcinoma(HCC)is a high mortality neoplasm which usually appears on a cirrhotic liver.The therapeutic arsenal and subsequent prognostic outlook are intrinsically linked to the HCC stage at diagnosis.Not...
关键词：Hepatocellular carcinoma Early stage Intermediate stage NEOADJUVANT ADJUVANT Systemic therapy 
ESMO 2023 pancreatic cancer guidelines signal stepwise progress
《Hepatobiliary Surgery and Nutrition》2024年第2期362-365,共4页Christoph Springfeld Peter Bailey Markus W.Büchler John P.Neoptolemos 
Pancreatic ductal adenocarcinoma(PDAC)is still a devastating disease,and for those who treat PDAC patients it sometimes seems that there is little to no relevant progress.The excellent new ESMO clinical practice guide...
关键词：Resectable BORDERLINE ADJUVANT NEOADJUVANT persister cells 
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023被引量：38
《Cancer Communications》2024年第1期127-172,共46页Feng-Hua Wang Xiao-Tian Zhang Lei Tang Qi Wu Mu-Yan Cai Yuan-Fang Li Xiu-Juan Qu Hong Qiu Yu-Jing Zhang Jie-Er Ying Jun Zhang Ling-Yu Sun Rong-Bo Lin Chang Wang Hao Liu Miao-Zhen Qiu Wen-Long Guan Sheng-Xiang Rao Jia-Fu Ji Yan Xin Wei-Qi Sheng Hui-Mian Xu Zhi-Wei Zhou Ai-Ping Zhou Jing Jin Xiang-Lin Yuan Feng Bi Tian-Shu Liu Han Liang Yan-Qiao Zhang Guo-Xin Li Jun Liang Bao-Rui Liu Lin Shen Jin Li Rui-Hua Xu 
The 2023 update of the Chinese Society of Clinical Oncology(CSCO)Clini-cal Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China,reflecting the latest advancements in evidence-...
关键词：Chinese Society of Clinical Oncology(CSCO) gastric cancer diagnosis surgery NEOADJUVANT ADJUVANT RADIOTHERAPY chemotherapy targeted therapy IMMUNOTHERAPY 
Current trends in perioperative treatment of resectable gastric cancer被引量：2
《World Journal of Gastrointestinal Surgery》2023年第3期323-337,共15页İbrahim Yıldız Leyla Özer Elif Şenocak Taşçı İbrahim Vedat Bayoglu Erman Aytac 
In the last few decades,the treatment strategy for locally advanced resectable gastric cancer(GC)has shifted to a multimodal approach,which potentially decreases recurrence risk and improves survival rates.Perioperati...
关键词：Perioperative treatment IMMUNOTHERAPY NEOADJUVANT CHEMOTHERAPY Gastric cancer ADJUVANT 
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
《四川生理科学杂志》2023年第3期467-467,共1页Sapna P Pate 
Background:Whether pembrolizumab given both before surgery(neoadjuvant therapy)and after surgery(adjuvant therapy),as compared with pembrolizumab given as adjuvant therapy alone,would increase event-free survival amon...
关键词：THERAPY ADJUVANT SURGERY 
Immunotherapy in Early Stage Non-Small Cell Lung Cancer
《Advances in Lung Cancer》2022年第3期31-44,共14页Jeyanthi Ramanarayanan Ganapathy Krishnan 
Immune-checkpoint inhibitors are extensively used in cancer treatment and have transformed the therapeutic landscape by inducing durable responses. Immunotherapy with checkpoint inhibitors targeting programmed death 1...
关键词：Non-Small Cell Lung Cancer IMMUNOTHERAPY Immune Checkpoint Inhibitors ADJUVANT NEOADJUVANT Early Stage 
Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer被引量：1
《World Journal of Clinical Oncology》2021年第10期912-925,共14页Miguel J Sotelo Jose Luis García Cesar Torres-Mattos Héctor Milián Carlos Carracedo María Angeles González-Ruiz Xabier Mielgo-Rubio Juan Carlos Trujillo-Reyes Felipe Couñago 
Patients with early-stage non-small-cell lung cancer(NSCLC)are candidates for curative surgery;however,despite multiple advances in lung cancer management,recurrence rates remain high.Adjuvant chemotherapy has been de...
关键词：Non-small-cell lung cancer Early stage Epidermal growth factor receptormutated Epidermal growth factor receptor-mutated-tyrosine kinase inhibitor ADJUVANT NEOADJUVANT 
The Chinese Society of Clinical Oncology(CSCO):Clinical guidelines for the diagnosis and treatment of gastric cancer,2021被引量：218
《Cancer Communications》2021年第8期747-795,共49页Feng-Hua Wang Xiao-Tian Zhang Yuan-Fang Li Lei Tang Xiu-Juan Qu Jie-Er Ying Jun Zhang Ling-Yu Sun Rong-Bo Lin Hong Qiu Chang Wang Miao-Zhen Qiu Mu-Yan Cai QiWu Hao Liu Wen-Long Guan Ai-Ping Zhou Yu-Jing Zhang Tian-Shu Liu Feng Bi Xiang-Lin Yuan Sheng-Xiang Rao Yan Xin Wei-Qi Sheng Hui-Mian Xu Guo-Xin Li Jia-Fu Ji Zhi-Wei Zhou Han Liang Yan-Qiao Zhang Jing Jin Lin Shen Jin Li Rui-Hua Xu 
There exist differences in the epidemiological characteristics,clinicopathological features,tumor biological characteristics,treatment patterns,and drug selections between gastric cancer patients from the Eastern and ...
关键词：ADJUVANT chemotherapy Chinese Society of Clinical Oncology(CSCO) diagnosis gastric cancer IMMUNOTHERAPY NEOADJUVANT RADIOTHERAPY surgery targeted therapy 
全选清除导出
共4页<1234>
检索报告 对象比较 聚类工具 使用帮助 返回顶部